article thumbnail

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

Am J Prev Med 2017; 53:S172-S181. doi:10.1016/20S0140-6736(22)02034-7 Aprocitentan (Tryvio) package insert. Widaplik (telmisartan, amlodipine, indapamide) package insert. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. Park C, Fang J, Hawkins NA, Wang G. doi:10.1016/j.amepre.2017.07.014 2017.07.014 Chernova I, Krishnan N.

article thumbnail

3 of the year’s most notable FDA nods

PharmaVoice

Of the 13 antibiotics OK’d for the market between mid-2017 and 2023, only two belonged to a new class of drugs, the WHO reported last year. The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion.

Vaccines 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

3 GlobalData’s analysis shows that the number of clinical trial investigators globally fell from approximately 128,303 in 2017-18 to 116,948 in 2023-24 – a decline of almost 10%. How will RFK Jr’s American dream for vaccines play out?

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

In addition, the TCI market is projected for significant growth, rising from $13m in 2017 to $30bn in 2030, says GlobalData. How will RFK Jr’s American dream for vaccines play out? Autologous therapies make up 76% of CGT treatments in development, compared with allogeneic cell therapies at 24% in oncology.

article thumbnail

Best CDMO Practices for Startups: Navigating the Complex World of Contract Development and Manufacturing

Drug Patent Watch

In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4]. Take the time to clearly define your technical needs, from drug substance manufacturing to packaging requirements.

article thumbnail

9 Sneaky Thyroid Toxins Hiding in Your Home

The Thyroid Pharmacist

10] Its not only found in obvious sources like plastic containers and packaging, but also in the lining of canned foods and drinks, receipts, toys, electronics, and household items. A 2017 study analyzed 159 samples of tap water from around the world. [11] Today, we can even find plastic in our drinking water. 2016;13(11):1153.

article thumbnail

EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL

Pharmaceutical Technology

The US Food and Drug Administration (FDA) approved Amgen’s Blincyto (blinatumomab), the first bispecific T-cell engager (BiTE), in 2014 for adults with Ph- R/R B-ALL, with its label expanded in 2017 to include Ph+ and paediatric cases. Give your business an edge with our leading industry insights.